Sh­iono­gi cel­e­brates an­tibi­ot­ic win in pneu­mo­nia just ahead of its date with FDA reg­u­la­tors

Just weeks be­fore Sh­iono­gi is sched­uled to hear back from the FDA on treat­ing com­pli­cat­ed uri­nary tract in­fec­tions with its an­tibi­ot­ic, the Japan­ese phar­ma has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.